0000899243-19-000296.txt : 20190103
0000899243-19-000296.hdr.sgml : 20190103
20190103163218
ACCESSION NUMBER: 0000899243-19-000296
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190102
FILED AS OF DATE: 20190103
DATE AS OF CHANGE: 20190103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Klein Lawrence Otto
CENTRAL INDEX KEY: 0001762583
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37923
FILM NUMBER: 19506038
MAIL ADDRESS:
STREET 1: C/O CRISPR THERAPEUTICS AG
STREET 2: 610 MAIN STREET 7TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CRISPR Therapeutics AG
CENTRAL INDEX KEY: 0001674416
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 473173478
STATE OF INCORPORATION: V8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: BAARERSTRASSE 14
CITY: ZUG
STATE: V8
ZIP: CH-6300
BUSINESS PHONE: 6173154600
MAIL ADDRESS:
STREET 1: BAARERSTRASSE 14
CITY: ZUG
STATE: V8
ZIP: CH-6300
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-01-02
0
0001674416
CRISPR Therapeutics AG
CRSP
0001762583
Klein Lawrence Otto
C/O CRISPR THERAPEUTICS, INC.
200 SIDNEY STREET
CAMBRIDGE
MA
02139
0
1
0
0
Chief Business Officer
Restricted Stock Units
2019-01-02
4
A
0
20000
29.87
A
20000
D
Stock Option (Right to Buy)
29.87
2019-01-02
4
A
0
20000
0.00
A
2029-01-01
Common Shares
20000
20000
D
Each restricted stock unit represents a contingent right to receive one CRSP common share.
The restricted stock units shall vest in full on January 2, 2021, subject to continued employment with the company.
25% of the option shall vest on January 2, 2020, and the remaining 75% of the shares shall vest in 36 equal monthly installments on the final day of each month.
/s/ Michael Esposito, as attorney-in-fact
2018-01-03